| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6023001 | Neurobiology of Disease | 2009 | 9 Pages |
Abstract
Our data suggest a role for D3 receptors in the development of LID and suggest that initiating L-DOPA treatment with a D3 antagonist may reduce the development of LID in PD.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Naomi P. Visanji, Susan H. Fox, Tom Johnston, Gabriela Reyes, Mark J. Millan, Jonathan M. Brotchie,